Establishment of a novel human amniotic epithelial-derived cell line, HAT, for high-yield AAV vector production.

Hirai Y, Chang YH, Yamamoto A, Asahina R, Moromizato R, Kinoshita M, Aizawa K, Miyai M, Kubota M, Horiuchi T, Nakamura K

Open source

DOI
10.1016/j.omtm.2025.101594
Published
2025 Dec 11
Container
Molecular therapy. Methods & clinical development
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.omtm.2025.101594,
  title = {Establishment of a novel human amniotic epithelial-derived cell line, HAT, for high-yield AAV vector production.},
  author = {Hirai Y and Chang YH and Yamamoto A and Asahina R and Moromizato R and Kinoshita M and Aizawa K and Miyai M and Kubota M and Horiuchi T and Nakamura K},
  year = {2025},
  journal = {Molecular therapy. Methods \& clinical development},
  doi = {10.1016/j.omtm.2025.101594},
  url = {https://doi.org/10.1016/j.omtm.2025.101594}
}

RIS

TY  - JOUR
TI  - Establishment of a novel human amniotic epithelial-derived cell line, HAT, for high-yield AAV vector production.
AU  - Hirai Y
AU  - Chang YH
AU  - Yamamoto A
AU  - Asahina R
AU  - Moromizato R
AU  - Kinoshita M
AU  - Aizawa K
AU  - Miyai M
AU  - Kubota M
AU  - Horiuchi T
AU  - Nakamura K
PY  - 2025
JO  - Molecular therapy. Methods & clinical development
DO  - 10.1016/j.omtm.2025.101594
UR  - https://doi.org/10.1016/j.omtm.2025.101594
ER  - 

APA

Y, H., YH, C., A, Y., R, A., R, M., M, K., K, A., M, M., M, K., T, H., & K, N. (2025). Establishment of a novel human amniotic epithelial-derived cell line, HAT, for high-yield AAV vector production.. Molecular therapy. Methods & clinical development. https://doi.org/10.1016/j.omtm.2025.101594

Source records